title: [Analysis on hypertension control and follow up among elderly patients with hypertension in communities].
abstract: OBJECTIVE
  To study hypertension control, follow up and the factors associated with the rate of hypertension control.
  
  
  METHODS
  Through a community-based study, the routine data were collected through a community hypertension managing software for one year.
  
  
  RESULTS
  There were 3375 hypertension patients above 60 years old recruited in the information system. In the baseline, the rate of blood pressure control was 63.5%, and arranging intervals up to 6 months was 66.9%. Hypertension control rate for the baseline, the third month and the sixth month was 61.8%, 62.4% and 61.6%, respectively (chi2 = 0.16, P = 0.69). Among hypertensives whose blood pressure was stabilized in baseline, hypertension control rates for the third month and the sixth month was 72.9.8% and 72.1%, respectively (chi2 = 0.26, P = 0.61). Blood pressure stabilized over 6 months in comparing with others, and the proportion for regular taking medication was 96.2% and 97.7% (chi2 = 3.58, P = 0.06). The proportion for physical activity, less salt intake, weight control was significantly higher in the patients whose blood pressure control well over 6 month.
  
  
  CONCLUSIONS
  Rate of blood pressure control among elderly patient with hypertension who frequently consults the doctor in the community is high. Ineffectiveness in systolic and diabetes control is the important factor, which decreases the rate of blood pressure. Physical activity, less salt intake, and weight control are of help to hypertension control. For those, the blood pressure are stabilized, a follow up with 3 to 6 months interval is appropriate.
authors.affiliation: Beijing An Zhen Hospital, Beijing Institute of Heart, Lung and Blood Vessel Diseases, Beijng 100029, China.
authors.forename: Yun
authors.initials: Y
authors.lastname: Lin
authors.forename: Hui-juan
authors.initials: HJ
authors.lastname: Zuo
authors.forename: Chun-rong
authors.initials: CR
authors.lastname: Feng
authors.forename: Juan
authors.initials: J
authors.lastname: Zhang
authors.forename: Shu-qian
authors.initials: SQ
authors.lastname: Liu
authors.forename: Xiao-hui
authors.initials: XH
authors.lastname: Yang
authors.forename: Yun-dai
authors.initials: YD
authors.lastname: Chen
authors.forename: Jin-rong
authors.initials: JR
authors.lastname: Zhang
authors.forename: Shu-zheng
authors.initials: SZ
authors.lastname: Lu
authors.forename: Chong-hua
authors.initials: CH
authors.lastname: Yao
mesh_terms: D000368:Aged; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001794:Blood Pressure; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000503:physiopathology; D008297:Male
chemical_list: D000959:Antihypertensive Agents